A Parkinson’s Wellness Program (formerly Delay the Disease) centered around those diagnosed with Parkinson’s disease will be hosted by Upper Valley Medical Center Jan. 6 through March 27, 2025.
“This gene-to-molecule research is crucial for discovery in Alzheimer’s disease. It offers fresh perspectives on how genetic risk factors, such as APOE, influence metabolism and perhaps disease ...
as a treatment for patients with unresectable or metastatic NRAS-mutant melanoma who have progressed on or are intolerant to PD-1/PD-L1 based immune checkpoint inhibitors. IMM-1-104 is currently being ...